Aktemra - pervyy i edinstvennyy biologicheskiy preparat, demonstriruyushchiy prevoskhodstvo nad sushchestvuyushchimi standartami terapii revmatoidnogo artrita

Novyy preparat dlya lecheniya revmatoidnogo artrita (RA) - Aktemra (totsilizumab) - prodemonstriroval prevoskhodstvo nad sushchestvuyushchim standartom terapii (metotreksat): posle 6 mes priema preparata nablyudaetsya bolee znachitel'noe snizhenie vyrazhennosti simptomov zabolevaniya (pripukhlo...

Full description

Saved in:
Bibliographic Details
Main Author: - -
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2008-09-01
Series:Современная ревматология
Online Access:https://mrj.ima-press.net/mrj/article/view/180
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849690521849561088
author - -
author_facet - -
author_sort - -
collection DOAJ
description Novyy preparat dlya lecheniya revmatoidnogo artrita (RA) - Aktemra (totsilizumab) - prodemonstriroval prevoskhodstvo nad sushchestvuyushchim standartom terapii (metotreksat): posle 6 mes priema preparata nablyudaetsya bolee znachitel'noe snizhenie vyrazhennosti simptomov zabolevaniya (pripukhlost' i boleznennost' sustavov) u patsientov, stradayushchikh RA1. Bolee togo, pri ispol'zovanii Aktemry primerno v 3raza bol'she patsientov (po sravneniyu s metotreksatom) dostigli remissii (po kriteriyam DAS 28 <2,6)2 - osnovnoy tseli terapii etogo poka neizlechimogo zabolevaniya1. Etot rezul'tat chrezvychayno vazhen, poskol'ku RA yavlyaetsya dlitel'nym invalidiziru-yushchim zabolevaniem i sushchestvuyushchie lekarstvennye sredstva dayut lish' nebol'shuyu nadezhdu na dostizhenie remissii; po sushchestvu, ostro neobkhodimy novye varianty terapii RA. Uil'yam M. Berns - glava podrazdeleniya Farma kompanii «Rosh»: «Dannye poslednikh issledovaniy yavlyayutsya obnadezhivayushchey novost'yu dlya patsientov, stradayushchikh ot razrushitel'nykh effektov RA. My verim, chto Aktemra - pervyy i edinstvennyy biologicheskiy preparat, demonstriruyushchiy preimushchestvo pered sushchestvuyushchimi standartami lecheniya RA, - oblegchit sostoyanie mnogikh bol'nykh. Krome togo, Aktemra predostavlyaet bol'she shansov dlya dostizheniya ranney i prodolzhitel'noy remissii».
format Article
id doaj-art-a12fb41f900049a792c33dbc0a8087ef
institution DOAJ
issn 1996-7012
2310-158X
language Russian
publishDate 2008-09-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj-art-a12fb41f900049a792c33dbc0a8087ef2025-08-20T03:21:18ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2008-09-0123787910.14412/1996-7012-2008-4951485Aktemra - pervyy i edinstvennyy biologicheskiy preparat, demonstriruyushchiy prevoskhodstvo nad sushchestvuyushchimi standartami terapii revmatoidnogo artrita- -Novyy preparat dlya lecheniya revmatoidnogo artrita (RA) - Aktemra (totsilizumab) - prodemonstriroval prevoskhodstvo nad sushchestvuyushchim standartom terapii (metotreksat): posle 6 mes priema preparata nablyudaetsya bolee znachitel'noe snizhenie vyrazhennosti simptomov zabolevaniya (pripukhlost' i boleznennost' sustavov) u patsientov, stradayushchikh RA1. Bolee togo, pri ispol'zovanii Aktemry primerno v 3raza bol'she patsientov (po sravneniyu s metotreksatom) dostigli remissii (po kriteriyam DAS 28 <2,6)2 - osnovnoy tseli terapii etogo poka neizlechimogo zabolevaniya1. Etot rezul'tat chrezvychayno vazhen, poskol'ku RA yavlyaetsya dlitel'nym invalidiziru-yushchim zabolevaniem i sushchestvuyushchie lekarstvennye sredstva dayut lish' nebol'shuyu nadezhdu na dostizhenie remissii; po sushchestvu, ostro neobkhodimy novye varianty terapii RA. Uil'yam M. Berns - glava podrazdeleniya Farma kompanii «Rosh»: «Dannye poslednikh issledovaniy yavlyayutsya obnadezhivayushchey novost'yu dlya patsientov, stradayushchikh ot razrushitel'nykh effektov RA. My verim, chto Aktemra - pervyy i edinstvennyy biologicheskiy preparat, demonstriruyushchiy preimushchestvo pered sushchestvuyushchimi standartami lecheniya RA, - oblegchit sostoyanie mnogikh bol'nykh. Krome togo, Aktemra predostavlyaet bol'she shansov dlya dostizheniya ranney i prodolzhitel'noy remissii».https://mrj.ima-press.net/mrj/article/view/180
spellingShingle - -
Aktemra - pervyy i edinstvennyy biologicheskiy preparat, demonstriruyushchiy prevoskhodstvo nad sushchestvuyushchimi standartami terapii revmatoidnogo artrita
Современная ревматология
title Aktemra - pervyy i edinstvennyy biologicheskiy preparat, demonstriruyushchiy prevoskhodstvo nad sushchestvuyushchimi standartami terapii revmatoidnogo artrita
title_full Aktemra - pervyy i edinstvennyy biologicheskiy preparat, demonstriruyushchiy prevoskhodstvo nad sushchestvuyushchimi standartami terapii revmatoidnogo artrita
title_fullStr Aktemra - pervyy i edinstvennyy biologicheskiy preparat, demonstriruyushchiy prevoskhodstvo nad sushchestvuyushchimi standartami terapii revmatoidnogo artrita
title_full_unstemmed Aktemra - pervyy i edinstvennyy biologicheskiy preparat, demonstriruyushchiy prevoskhodstvo nad sushchestvuyushchimi standartami terapii revmatoidnogo artrita
title_short Aktemra - pervyy i edinstvennyy biologicheskiy preparat, demonstriruyushchiy prevoskhodstvo nad sushchestvuyushchimi standartami terapii revmatoidnogo artrita
title_sort aktemra pervyy i edinstvennyy biologicheskiy preparat demonstriruyushchiy prevoskhodstvo nad sushchestvuyushchimi standartami terapii revmatoidnogo artrita
url https://mrj.ima-press.net/mrj/article/view/180
work_keys_str_mv AT aktemrapervyyiedinstvennyybiologicheskiypreparatdemonstriruyushchiyprevoskhodstvonadsushchestvuyushchimistandartamiterapiirevmatoidnogoartrita